You just read:

Spinifex Pharmaceuticals' Phase 2 Results Published in The Lancet Show EMA401 to be Effective in Reducing Pain in Postherpetic Neuralgia

News provided by

Spinifex Pharmaceuticals

05 Feb, 2014, 08:00 GMT